Croton tiglium L. seeds ameliorate loperamide-induced constipation via regulating gastrointestinal hormones and gut microbiota before and after processing

被引:4
作者
Jia, Ze-Fei [1 ]
Wang, Jia-Li [1 ]
Pan, Wen [1 ]
Hu, Jing [1 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Therapeut Subst Tradit Chinese Med, 10 Poyanghu Rd, Tianjin 301617, Peoples R China
基金
中国国家自然科学基金;
关键词
Croton tiglium L; Processing; Constipation; Gut microbiota; INTESTINAL TRANSIT; PHORBOL ESTERS; CA2+ INFLUX; ACTIVATION; OIL; EXTRACTION; CELLS; FLORA;
D O I
10.1016/j.jep.2023.117378
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Crotonis Fructus (CF), the seeds of Croton tiglium L., have been commonly used in the treatment of constipation for more than two thousand years in traditional Chinese medicine (TCM). CF needs to be processed before clinical use and Crotonis Semen Pulveratum (CP) is the processed cream of CF, which could reduce the drastic purgative action and gastrointestinal damages. However, the mechanism of CF and CP in the treatment of constipation is still unclear.Aim of the study: This study was to evaluate the effects of CF and CP on loperamide-induced constipation and the underlying mechanism.Materials and methods: The chemical compositions of CF and CP were analyzed by UPLC-Q-TOF-MS. Constipated mouse model was established by loperamide (9.6 mg/kg, b.w., i.g.) for two weeks. After successful modeling, the mice were treated with CF or CP (45.5 and 136.5 mg/kg, b.w., i.g.) once a day for seven days. The physiological status, defecation indices, defecation time, and intestinal propulsion rate in mice were measured. Histopathologic examination and serum biochemical parameters were further estimated. 16S rDNA gene sequencing was carried out to characterize the effects of CF and CP on intestinal microbiome structure. Spearman correlation analysis was also performed to explore the association between gut microbiotic abundance and serum indices.Results: The results verified the therapeutic effects of CF and CP on loperamide-induced constipation. CF and CP could significantly ameliorate the reduction of fecal number, fecal weight, fecal water content, and intestinal propulsion rate in mice with constipation, and the first stool defecation time was also obviously reduced. Moreover, CF and CP could regulate the secretion of gastrointestinal hormones and inflammatory factors induced by constipation. Histopathologic examination showed that CP was superior to CF in relieving pathological injury and inflammatory cell infiltration. According to 16S rDNA sequencing, CF and CP treatment could improve gut microbiota disturbance in mice with constipation and the abundance of opportunistic pathogens such as Parabacteroides, Parasutterella and Bacillus remarkably declined, while the levels of beneficial bacterial such as Candidatus_Arthromitus significantly increased. Besides, CP may play a better role in correcting the intestinal flora disorder than CF, which was more obvious in the high-dose group. In addition, phytochemical analysis revealed the presence of diterpenoids and alkaloids in CF and CP.Conclusions: CF and CP could ameliorate loperamide-induced constipation by regulating gastrointestinal hormones secretion, reducing the levels of inflammatory cytokines and improving the disturbance of gut microbiota. Moreover, CP was superior to CF in the enrichment of beneficial bacteria and reduction of harmful bacteria and histopathological damage induced by constipation, which may be related to the changes in the species and content of diterpenoids after processing. The study provides new evidence for the processing mechanism and clinical application of CF and CP.
引用
收藏
页数:15
相关论文
共 71 条
  • [11] Ehling-Schulz M, 2019, MICROBIOL SPECTR, V7, DOI [10.1128/microbiolspec.GPP3-0032-2018, 10.1128/microbiolspec.gpp3-0032-2018]
  • [12] Abnormal rectal endocrine cells in patients with irritable bowel syndrome
    El-Salhy, Magdy
    Gundersen, Doris
    Hatlebakk, Jan G.
    Gilja, Odd Helge
    Hausken, Trygve
    [J]. REGULATORY PEPTIDES, 2014, 188 : 60 - 65
  • [13] Gut microbiota in human metabolic health and disease
    Fan, Yong
    Pedersen, Oluf
    [J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (01) : 55 - 71
  • [14] Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet
    Farzi, Aitak
    Ip, Chi Kin
    Reed, Felicia
    Enriquez, Ronaldo
    Zenz, Geraldine
    Durdevic, Marija
    Zhang, Lei
    Holzer, Peter
    Herzog, Herbert
    [J]. FASEB JOURNAL, 2021, 35 (04)
  • [15] Chronic Constipation in the Elderly
    Gallegos-Orozco, Juan F.
    Foxx-Orenstein, Amy E.
    Sterler, Susan M.
    Stoa, Jean M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01) : 18 - 25
  • [16] Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
    Grenda, Anna
    Iwan, Ewelina
    Krawczyk, Pawel
    Frak, Malgorzata
    Chmielewska, Izabela
    Bomba, Arkadiusz
    Giza, Aleksandra
    Rolska-Kopinska, Anna
    Szczyrek, Michal
    Kieszko, Robert
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Wasyl, Dariusz
    Milanowski, Janusz
    [J]. CANCERS, 2022, 14 (24)
  • [17] Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
    Harmar, Anthony J.
    Fahrenkrug, Jan
    Gozes, Illana
    Laburthe, Marc
    May, Victor
    Pisegna, Joseph R.
    Vaudry, David
    Vaudry, Hubert
    Waschek, James A.
    Said, Sami I.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) : 4 - 17
  • [18] Activation of M3 muscarinic receptor and Ca2+ influx by crude fraction from Crotonis Fructus in isolated rabbit jejunum
    Hu, Jing
    Gao, Wen-Yuan
    Ma, Lin
    Man, Shu-Li
    Huang, Lu-Qi
    Liu, Chang-Xiao
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2012, 139 (01) : 136 - 141
  • [19] M3 muscarinic receptor- and Ca2+ influx-mediated muscle contractions induced by croton oil in isolated rabbit jejunum
    Hu, Jing
    Gao, Wen-Yuan
    Gao, Ying
    Ling, Ning-Sheng
    Huang, Lu-Qi
    Liu, Chang-Xiao
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2010, 129 (03) : 377 - 380
  • [20] Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota
    Huang, Pan
    Wang, Xuxin
    Wang, Siyu
    Wu, Zhipeng
    Zhou, Zhengrong
    Shao, Genbao
    Ren, Caifang
    Kuang, Meiqian
    Zhou, Yan
    Jiang, Anqi
    Tang, Weihong
    Miao, Jianye
    Qian, Xin
    Gong, Aihua
    Xu, Min
    [J]. CURRENT RESEARCH IN FOOD SCIENCE, 2022, 5 : 1403 - 1411